It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Zika virus (ZIKV), an emerging mosquito-borne flavivirus, is associated with congenital neurological complications. Here, we investigate potential pathological correlates of virus gene expression in representative ZIKV strains through RNA sequencing and ribosome profiling. In addition to the single long polyprotein found in all flaviviruses, we identify the translation of unrecognised upstream open reading frames (uORFs) in the genomic 5′ region. In Asian/American strains, ribosomes translate uORF1 and uORF2, whereas in African strains, the two uORFs are fused into one (African uORF). We use reverse genetics to examine the impact on ZIKV fitness of different uORFs mutant viruses. We find that expression of the African uORF and the Asian/American uORF1 modulates virus growth and tropism in human cortical neurons and cerebral organoids, suggesting a potential role in neurotropism. Although the uORFs are expressed in mosquito cells, we do not see a measurable effect on transmission by the mosquito vector in vivo. The discovery of ZIKV uORFs sheds new light on the infection of the human brain cells by this virus and raises the question of their existence in other neurotropic flaviviruses.
Here the authors identify upstream open reading frames (uORFs), uORF1 and uORF2 in the Asian/American lineage and African uORF in the African lineage of Zika viruses, and show that uORF1 affects vimentin filaments and that the identified uORFs affect virus replication in neural cells.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details














1 University of Cambridge, Division of Virology, Department of Pathology, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000 0001 2188 5934)
2 University of Cambridge, Division of Virology, Department of Pathology, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000 0001 2188 5934); University of Cambridge, Department of Medicine, MRC Laboratory of Molecular Biology, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
3 Insect-Virus Interactions Unit, Institut Pasteur, Université Paris Cité, CNRS UMR2000, Paris, France (GRID:grid.5335.0)
4 University of Cambridge, John van Geest Centre for Brain Repair, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000 0001 2188 5934)
5 University of Cambridge, Cambridge Institute for Medical Research, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000 0001 2188 5934)
6 University of Cambridge, Division of Immunology, Department of Pathology, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000 0001 2188 5934)
7 University of Cambridge, John van Geest Centre for Brain Repair, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000 0001 2188 5934); Cambridge Stem Cell Institute, Cambridge, UK (GRID:grid.449973.4) (ISNI:0000 0004 0612 0791)
8 Insect-Virus Interactions Unit, Institut Pasteur, Université Paris Cité, CNRS UMR2000, Paris, France (GRID:grid.449973.4)